Core Viewpoint - Charter Communications reported a smaller-than-expected decline in broadband subscribers for the fourth quarter, supported by its internet offerings that can be bundled with high-speed mobile services [1] Group 1: Subscriber Performance - The decline in broadband subscribers was less than anticipated, indicating a potential stabilization in customer retention [1] - The company's ability to bundle internet services with mobile offerings may have contributed to this performance [1]

Core Insights - Apple watches are demonstrating effectiveness in screening for atrial fibrillation (AFib), a common heart rhythm disorder, as evidenced by two studies published in the Journal of the American College of Cardiology [1] Group 1 - The studies indicate that Apple watches can be a valuable tool in identifying AFib, potentially leading to earlier diagnosis and treatment [1] - The findings may enhance the role of wearable technology in healthcare, particularly in monitoring heart health [1]

Core Insights - Canadian oil producer Imperial Oil reported a decline in fourth-quarter profit due to a decrease in crude prices [1] Company Summary - Imperial Oil's fourth-quarter profit fell as a result of lower crude oil prices impacting revenue [1]

Core Viewpoint - Colgate-Palmolive forecasts annual sales exceeding Wall Street estimates, driven by consistent demand for essential household products in regions like Latin America and Europe [1] Group 1 - The company is experiencing steady demand for its products, which is contributing to its positive sales outlook [1] - The forecast indicates a strong performance in key markets, particularly in Latin America and Europe [1]

Petrochemicals maker LyondellBasell on Friday posted a surprise loss for the fourth quarter and said it aims to save $1.3 billion by the end of 2026, as it continues to keep a tight lid on costs amid volatility in feedstock and energy prices. ...

Core Viewpoint - U.S. drugmaker Regeneron Pharmaceuticals exceeded analysts' profit expectations for the fourth quarter, driven by robust demand for its eczema treatment, Dupixent [1] Company Summary - Regeneron Pharmaceuticals reported a strong performance in the fourth quarter, attributed to the high demand for its eczema treatment, Dupixent [1]

Core Viewpoint - Caixabank anticipates an increase in lending income and profits for this year and the next, attributed to robust loan growth as Spain's economy outperforms the rest of the euro zone [1] Group 1 - The company expects stronger loan growth to drive its financial performance [1] - Spain's economic performance is highlighted as a key factor in Caixabank's positive outlook [1]

Core Insights - Novo Nordisk's Wegovy pill achieved over 26,000 prescriptions in the U.S. during the second full week following its launch, indicating strong initial demand for the product [1] Group 1 - Wegovy's prescription numbers reflect a significant uptake in the market, showcasing the potential for growth in the obesity treatment sector [1]

SoFi Technologies reported a rise in fourth-quarter profit on Friday, lifted by strong loan demand and rapid growth in its feebased businesses. ...

Everything Mike Dolan and the ROI team are excited to read, watch and listen to over the weekend. ...